Stefano Jaconi Email and Phone Number
Key achievements in Biotechnology and Pharma industry experience, specific tools and techniques, collaborative and leadership roles: • CMC Analytics Expertise: Led analytical method development and preclinical assessment of recombinant proteins and monoclonal antibodies (mAbs), focusing on the characterization and monitoring of Critical Quality Attributes (CQAs) using cutting-edge UHPLC/UPLC technologies. • Protein Engineering & Antibody Technologies: Designed and optimized recombinant proteins and therapeutic antibodies, leveraging rational design strategies to enhance functionality and developability. Proficient in antibody humanization, affinity maturation, and Fc engineering for improved efficacy. • Upstream and Downstream Processing: Extensive experience in scaling biomanufacturing processes for mAbs, including cell culture optimization (CHO/Sf9) and downstream purification techniques such as Protein A/G chromatography, ion-exchange chromatography, and size-exclusion chromatography (SEC). • Quality Control (QC) and Regulatory Compliance: Established and validated QC processes to ensure compliance with ICH guidelines and Good Manufacturing Practices (GMP) for preclinical and clinical biologics. • Preclinical Developability Assessment: Successfully conducted stability studies, aggregation analysis, glycosylation profiling, and immunogenicity prediction for mAbs in early-stage R&D pipelines. • Analytical Technologies: Advanced proficiency in mass spectrometry (MS), dynamic light scattering (DLS), capillary electrophoresis (CE), and peptide mapping, ensuring the comprehensive analysis of therapeutic proteins. • Collaborative Contributions: Played a pivotal role in cross-functional teams, bridging R&D, process development, and regulatory functions to accelerate project timelines and deliver high-quality therapeutic candidates. • Industry Leadership: Worked with leading Biopharma and Biotech companies, driving innovations in mAb discovery, production, and QC while maintaining an acute focus on patient safety and product integrity.https://www.ticinoscienza.ch/cerca.php
Onk Onlynoseknows Ai-It Biotech Consulting Company
View- Website:
- onlynoseknows.ch
- Employees:
- 1
-
C-Suite, Founder And Managing DirectorOnk Onlynoseknows Ai-It Biotech Consulting CompanyAgno, Ti, Ch -
Ceo FounderSwissbiotechsolutions Company Startup Jan 2022 - PresentLugano Metropolitan Area -
FounderSwissbiotechsolutions Company Startup Jan 2022 - Jan 2025Lugano Metropolitan AreaAnalysis of monoclonal antibodies -
Senior Research AssociateVir Biotechnology, Inc. Sep 2017 - Jan 2022Bellinzona, Ticino, SwitzerlandDownstream processing of recombinant monoclonal antibodies, QC and Developability assessment. Analysis of mAbs CQA by UHPLC. -
Senior Research AssociateVir Biotechnology, Inc. Apr 2015 - Jan 2022Bellinzona, Ticino, Switzerland -
Senior Research AssociateHumabs Biomed, Subsidiary Of Vir Biotechnology Apr 2016 - Jan 2022Bellinzona, Ticino, SwitzerlandDownstream processing of recombinant monoclonal antibodies, QC and Developability assessment. Analysis of mAbs CQA by UHPLC. -
Biochemical Engineer EtUniversité De Genève - Faculty Of Medicine - Pathology And Immunology Department Oct 2014 - Mar 2015GenevaTechnology Expert in cellular and molecular biology on a project entitled "Culture and characterisation of human mesangioblasts for the cell therapy of muscular dystrophy" -
Laboratory TechnicianChuv | Lausanne University Hospital - Medical Genetic Department - Lab. Cytogènetique Du Cancer Jul 2013 - Jul 2014Lausanne Area, SwitzerlandDevelopment technician on NGS (Next Generation Sequencing).Training of others Laboratory users of the PGM next-generation high throughput Sequencing System. -
Technology ExpertMerck Serono Apr 2007 - Dec 2012Geneva Area, SwitzerlandR&D - New Biological Entities Technologies - Protein Engineering and Antibody Technologies (NBE-PEAT)• Implementation of Phage Display Technology Platform for generation of monoclonal Antibodies- Installation/operation & troubleshooting of core automated systems that support the antibody phage display 96/386-well screening platform- Execution of phage display hit discovery & affinity maturation campaigns including method validation/optimisation and assessment of new techniques when necessary- Multi-modal phage selections/panning using large scFv phagemids libraries against different target classes and in different formats- Elaboration, optimization/validation of associated HTS ELISA-based screening assays- Rearraying of scFv hit clone panels- Affinity ranking by Biacore 4000 (GE Healthcare) - Surface Plasmon Resonance (SPR)ligand-binding assay- Problems solving; giving recommendations for upgrades / system modifications.• Laboratory key responsibilities for the discovery and early optimization of antibody therapeuticdrug candidates• Quality Delegate (QD) for the Merck Serono Quality Management System (MS-QMS): Internal Dept. Auditor.• Write and revise Laboratory Standard Operating Procedures (SOPs) -
Qms Qualified PersonMerck Group Dec 2002 - Dec 2012Geneva, Switzerland -
Assistant ScientistSerono Pharmaceutical Research Institute Apr 2004 - Mar 2007Geneva Area, SwitzerlandR&D Functional Genomics Department - Gene Discovery Group-Overall responsibility of the DNA Sequencing Service-Subcloning of Inpharmatica predicted genes by Gateway Technology and generation of expression clones for Bioprocessing Department and infection in FastTrack Proof-of-concept (POC) animal model -
Senior Research TechnicianSerono Pharmaceutical Research Institute Nov 2002 - Mar 2004Geneva Area, SwitzerlandR&D Functional Genomics Department - Gene Discovery Group-In charge of DNA Sequencing ServiceProteomics Signal Transduction Department-Gene cloning and Genotyping Analysis -
Research Technician In Molecular BiologyHôpitaux Universitaires De Genève - Biology Of Ageing Laboratory - Geriatric Hospital Jan 2000 - Dec 2002Région De Genève, SuisseResearch on Hypoxia factors, proton channels, Ribozimes, differentiation of mouse embryonic stem cells.Responsible for the website of the Biology of Ageing Laboratory. -
Research Technician In Molecular BiologyUniversité De Genève - Faculty Of Medicine - Physiology Dept & Surgical Intensive Care Dept Jan 1997 - Dec 1999Région De Genève, SuisseResearch collaboration project on nicotinic acetylcholine receptor-related protein in human leukocytes purified from bone marrow issued from patients undergoing cardiac surgery. -
Research Technician In BiochemistryHôpitaux Universitaires De Genève - Dermatology Department 1989 - 1996Région De Genève, SuisseResearch at Dermatology Department. Publications and Seminar on human serum retinol- binding protein.
Stefano Jaconi Education Details
-
Faculty Of Sciences – Biochemistry Master Studies -
Technical Evening Engineering School - Geneva Industrial CoursesDiploma -
Biochemistry
Frequently Asked Questions about Stefano Jaconi
What company does Stefano Jaconi work for?
Stefano Jaconi works for Onk Onlynoseknows Ai-It Biotech Consulting Company
What is Stefano Jaconi's role at the current company?
Stefano Jaconi's current role is C-suite, Founder and Managing Director.
What schools did Stefano Jaconi attend?
Stefano Jaconi attended University Of Geneva, Technical Evening Engineering School - Geneva Industrial Courses, University Of Geneva.
Not the Stefano Jaconi you were looking for?
-
Stefano Jaconi
Lugano -
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial